AURASTOP ® in the Treatment of Migraine Aura

@article{Dalla2018AURASTOPI,
  title={AURASTOP {\textregistered} in the Treatment of Migraine Aura},
  author={Volta Giorgio Dalla and Fabio Antonaci and Valentina Rebecchi and Grazia Sances and Paola Merlo and Ambra Giorgetti and Franco Di Palma and Eleanor Matta and Carlo Dallocchio and Cristina Tassorelli and Alessandro Pezzini and Giorgio Dalla Volta and Italia and Ommega Internationals},
  journal={International journal of neurology},
  year={2018},
  volume={5},
  pages={11-14}
}
Received date: July 14, 2018 Accepted date: August 10, 2018 Published date: August 15, 2018 1 Headache Science Centre, Istituto Neurologico Nazionale Mondino, Pavia 2 UC Neurologia Speciale d’Urgenza, Istituto Neurologico Nazionale, Pavia 3 Dipartimento di Scienze del Sistema Nervoso e del Comportamento Università di Pavia 4 Centro Cefalee UOC Neurologia -VareseASST Settelaghi – Università dell’ Insubria 5 U.O.NeurologiaCentro Cefalee, Humanitas Gavazzeni, Bergamo 6 Centro Cefalee, Dipartimento… 

Figures and Tables from this paper

Comparison of the Effect of Tanacethum Parthenium, 5-Hydroxy Tryptophan, and Magnesium (Aurastop) versus Magnesium Alone on Aura Phenomenon and Its Evolution

The hypothesis that Aurastop might be effective in interfering with the phenomenon of aura is supported and evidence that the clinical benefit attributable to this combination of molecules might be greater than that obtained with single compounds of proven effect on the biology of migraine is provided.

Comparison of the Effect of Tanacethum Parthenium, 5-Hydroxy Tryptophan, and Magnesium (Aurastop) versus Magnesium Alone on Aura Phenomenon and Its Evolution

The hypothesis that Aurastop might be effective in interfering with the phenomenon of aura is supported and evidence that the clinical benefit attributable to this combination of molecules might be greater than that obtained with single compounds of proven effect on the biology of migraine is provided.

Efficacy of a Combination of Tanacetum parthenium, 5-Hydroxy Tryptophan and Magnesium (Aurastop) in the Prevention of High Frequency Migraine with Aura

Object: To verify the efficacy and safety of the new combination of Tanacetum parthenium 150 mg, 5-hydrossitriptophan (5-HTTP) 20 mg and magnesium 185 mg (Aurastop) in the prophylactic treatment of

The Role of Magnesium in Pathophysiology and Migraine Treatment

The role of MG in migraine pathogenesis and the potential utilizations of Mg in the prevention and treatment of migraine with the emphasis on transdermal magnesium delivery are summarized.

References

SHOWING 1-10 OF 19 REFERENCES

Migraine aura: new ideas about cause, classification, and clinical significance.

Regardless of its exact role in the genesis of migraine, an increased understanding of aura has the potential to provide important new insight into not only migraine but also fundamental mechanisms of brain physiology.

A randomized controlled trial of intranasal ketamine in migraine with prolonged aura

These data provide translational evidence for the potential importance of glutamatergic mechanisms in migraine aura and offer a pharmacologic parallel between animal experimental work on cortical spreading depression and the clinical problem.

International Classification of Headache Disorders

  • J. Olesen
  • Medicine, Psychology
    The Lancet Neurology
  • 2018

A Combination of Tanacetum parthenium, Griffonia simplicifolia and Magnesium (Aurastop) as Symptomatic Acute Treatment for Migraine Aura: A Retrospective Cohort Study

The combined and synergistic effect of Tanacetum parthenium, Griffonia simpliciofila and Magnesium (Aurastop) highlights the idea that symptomatic treatment potentially modulating cortical spreading depression could deserve attention to mitigate aura and related symptoms (migraine as well as long-lasting discomfort).

Parthenolide is the Component of Tanacetum Parthenium that Inhibits Nitroglycerin-Induced Fos Activation: Studies in an Animal Model of Migraine

Findings strongly suggest that parthenolide is the component responsible for the biological activity of TP as regards its antimigraine effect and provide important information for future controlled clinical trials.

Unexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood–brain barrier permeability

Investigation of the effects of two N-methyl-D-aspartate receptor antagonists, endogenous kynurenic acid (KYNA) and dizocilpine, on CSD and the related blood–brain barrier permeability in rats suggests that KYNA itself or its derivatives may offer a new approach in the therapy of migraines.

Role of magnesium in the pathogenesis and treatment of migraine

The pathogenesis of migraine will be discussed, with an emphasis on the role of magnesium, and studies on the use of intravenous and oral magnesium in migraine treatment will be discussing and recommendations will be made regarding theUse of magnesium in treating migraine headaches.

Kynurenic acid modulates experimentally induced inflammation in the trigeminal ganglion

The CFA-induced inflammatory model for the TG activation provided a time-related expression of MAPK (pERK1/2, pp38) and NF-κB, which points to possible neuron-glia interactions during this process.